According to @QCompounding, a growing number of publicly traded companies are adopting Bitcoin (BTC) treasury strategies, with healthcare firms being the latest to join the trend. Prenetics Global Limited (NASDAQ: PRE) recently announced its first $20 million BTC acquisition, facilitated by the Kraken exchange, and has board approval to significantly increase its holdings. In a related move, South Korean biotech company Bridge Biotherapeutics (288330) received a $183.3 million investment from crypto firm Parataxis to build its own BTC treasury. Following the announcement, Bridge Biotherapeutics' shares surged over 20.5%. This strategy emulates that of firms like MicroStrategy (MSTR) and Metaplanet (3350), which have seen their stock prices rise as they become bitcoin-proxy assets for traders. Prenetics also strengthened its crypto expertise by appointing former OKEx COO Andy Cheung to its Board of Directors.